Peter Böhlen
Baebies (United States) · 255 works · 33,826 citations · h-index 91
Top works
- Fluorescamine: A Reagent for Assay of Amino Acids, Peptides, Proteins, and Primary Amines in the Picomole Range
- Fluorometric assay of proteins in the nanogram range
- Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF.
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
- Amino acid analysis with fluorescamine at the picomole level
- Growth Hormone-Releasing Factor from a Human Pancreatic Tumor That Caused Acromegaly
- Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor
- Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyl transferase.
- Isolation and partial molecular characterization of pituitary fibroblast growth factor.
- Automatic monitoring of primary amines in preparative column effluents with fluorescamine
- Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.
- Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
- High-sensitivity amino acid analysis: Methodology for the determination of amino acid compositions with less than 100 picomoles of peptides
- Transforming growth factor-beta inhibits endothelial cell proliferation
- Molecular Characterization of Fibroblast Growth Factor: Distribution and Biological Activities in Various Tissues
- Acidic fibroblast growth factor (FGF) from bovine brain: amino‐terminal sequence and comparison with basic FGF.
- Inhibitory action of transforming growth factor beta on endothelial cells.
- Isolation of pituitary fibroblast growth factor by fast protein liquid chromatography (FPLC): Partial chemical and biological characterization
- Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1
- Purification of kidney epithelial cell growth inhibitors.